Drug-metabolizing cytochrome P450s in the brain

Journal of Psychiatry and Neuroscience

Volumn 27, Issue 6, 2002, Pages 406-415

  Miksys, Sharon L ^a   Tyndale, Rachel F ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 3 METHYLCHOLANTHRENE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ARACHIDONIC ACID; BRAIN ENZYME; COCAINE; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; CYTOCHROME P450 2B; CYTOCHROME P450 2C; CYTOCHROME P450 2C13; CYTOCHROME P450 2D; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; INSECTICIDE; NEUROLEPTIC AGENT; NEUROSTEROID; PHENOBARBITAL; PHENYTOIN; SEROTONIN UPTAKE INHIBITOR; STEROID HORMONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

BLOOD BRAIN BARRIER; BRAIN METABOLISM; BRAIN REGION; CELL COMPOSITION; CELL KINETICS; DOPAMINE METABOLISM; DRUG BRAIN LEVEL; DRUG CLEARANCE; DRUG METABOLISM; DRUG TRANSPORT; ENZYME LOCALIZATION; ENZYME REGULATION; HUMAN; NEUROTRANSMISSION; NONHUMAN; NOTE; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIDE EFFECT; TRANSPORT KINETICS; XENOBIOTIC METABOLISM;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ARACHIDONIC ACID; BRAIN; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; NEUROTRANSMITTER AGENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEROIDS;

EID: 0036874345     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (165)

1. Warner M, Kohler C, Hansson T, Gustafsson J-A. Regional distribution of cytochrome P450 in the rat brain: spectral quantitation and contribution of P-450b,e and P-450c,d. J Neurochem 1988;50:1057-65.
2. Strobel HW, Thompson CM, Antonovic L. Cytochrome P450 in brain: function and significance. Curr Drug Metab 2001;2:199-214.
3. Miksys S, Hoffmann E, Tyndale RF, Regional and cellular induction of nicotine-metabolizing CYP2B1 in rat brain by chronic nicotine treatment. Biochem Pharmacol 2000;59:1501-11.
4. Miksys S, Rao Y, Hoffmann E, Mash DC, Tyndale RF. Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics. J Neurochem 2002;82(6):1376-87.
5. Siegle I, Fritz P, Eckhardt K, Zanger UM, Eichelbaum M. Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brain. Pharmacogenetics 2001;11:237-45.
6. Ghersi-Egea JF, Leininger-Muller B, Cecchelli R, Fenstermacher JD. Blood-brain interfaces: relevance to cerebral drug metabolism. Toxicol Lett 1995;82/83:645-53.
7. Ghersi-Egea JF, Leininger-Muller B, Suleman G, Siest G, Minn A. Localization of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs. J Neurochem 1994;62:1089-96.
8. Dey A, Jones JE, Nebert DW. Tissue- and cell type-specific expression of cytochrome P450 1A1 and cytochrome P450 1A2 mRNA in the mouse localized in situ hybridization. Biochem Pharmacol 1999;58:525-37.
9. Huang P, Rannug A, Ahlbom E, Hakansson H, Ceccatelli S. Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the expression of cytochrome P450 1A1, the aryl hydrocarbon receptor, and the aryl hydrocarbon receptor nuclear translocator in rat brain pituitary. Toxicol Appl Pharmacol 2000;169:159-67.
10. Morse DC, Stein AP, Thomas PE, Lowndes HE. Distribution and induction of cytochrome P450 1A1 and 1A2 in rat brain. Toxicol Appl Pharmacol 1998;152:232-9.
11. Volk B, Hettmannsperger U, Papp T, Amelizad Z, Oesch F, Knoth R. Mapping of phenytoin-inducible cytochrome P450 immunoreactivity in the mouse central nervous system. Neurosci 1991;42:215-35.
12. Miksys S, Rao Y, Sellers EM, Kwan M, Mendis D, Tyndale RF. Regional and cellular distribution of CYP2D subfamily members in rat brain. Xenobiotica 2000;30:547-64.
13. Norris PJ, Hardwick JP, Emson PC. Regional distribution of cytochrome P450 2D1 in the rat central nervous system. J Comp Neurol 1996;366:244-58.
14. Farin FM, Omiecinski CJ. Regiospecific expression of cytochrome P-450s and microsomal expoxide hydrolase in human brain tissue. J Toxicol Environ Health 1993;40:317-35.
15. Riedl AG, Watts PM, Edwards RJ, Boobis AR, Jenner P, Marsden CD. Selective localisation of P450 enzymes and NADPH-P450 oxidoreductase in rat basal ganglia using anti-peptide antisera. Brain Res 1996;743:324-8.
16. Schilter B, Omiecinski CJ. Regional distribution and expression modulation of cytochrome P-450 and epoxide hydrolase mRNAs in the rat brain. Mol Pharmacol 1993;44:990-6.
17. Agundez JA, Gallardo L, Martinez C, Gervasini G, Benitez J. Modulation of CYP1A2 enzyme activity by indoleamines: inhibition by serotonin and tryptamine. Pharmacogenetics 1998;8:251-8.
18. Yun C-H, Park H-J, Kim S-J, Kim H-K. Identification of cytochrome P450 1A1 in human brain. Biochem Biophys Res Commun 1998;243:808-10.
19. McFadyen MCE, Melvin WT, Murray GI. Regional distribution of individual forms of cytochrome P450 mRNA in normal adult human brain. Biochem Pharmacol 1998;55:825-30.
20. Murray GI, Taylor MC, McFadyen MC, McKay JA, Greenlee WF, Burke MD, et al. Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res 1997;57:3026-31.
21. Rieder CRM, Parsons RB, Fitch NJS, Williams AC, Ramsden DB. Human brain cytochrome P450 1B1: immunohistochemical localization in human temporal lobe and induction by dimethylbenz(a)anthracene in astrocytoma cell line (MOG-GCCM). Neurosci Lett 2000;278:177-80.
22. Rieder CRM, Ramsden DB, Williams AC. Cytochrome P450 1B1 mRNA in the human central nervous system. Mol Pathol 1998;51:138-42.
23. Muskhelishvili L, Thomplson PA, Kusewitt DF, Wang C. In situ hybridization and immunohistochemical analysis of cytochrome P450 1B1 expression in human normal tissues. J Histochem Cytochem 2001;49:229-36.
24. Anandatheerthavarada HK, Shankar SK, Ravindranath V. Rat brain cytochromes P450: catalytic, immunochemical properties and inducibility of multiple forms. Brain Res 1990;536:339-43.
25. Volk B, Meyer RP, von Lintig F, Ibach B, Knoth R. Localization and characterization of cytochrome P450 in the brain. In vivo and in vitro investigations on phenytoin- and phenobarbital-inducible forms. Toxicol Lett 1995;82-83:655-62.
26. Rosenbrock H, Hagemeyer CE, Ditter M, Knoth R, Volk B. Expression and localization of the CYP2B subfamily predominantly in neurones of rat brain. J Neurochem 2001;76:332-40.
27. Bhagwat SV, Boyd MR, Ravindranath V. Multiple forms of cytochrome P450 and associated monooxygenase activities in human brain mitochondria. Biochem Pharmacol 2000;59:573-82.
28. Bhamre S, Anandatheerathavarada HK, Shankar SK. Purification of multiple forms of cytochrome P450 from a human brain and reconstitution of catalitic activities. Arch Biochem Biophys 1993;301:251-5.
29. Gervot L, Rochat B, Gautier JC, Bohnenestengel F, Kroemer H, Berardinis VD, et al. Human CYP2B6 expression, inducibility and catalytic activities. Pharmacogenetics 1999;9:295-306.
30. Miksys SL, Schoedel KA, Mash DC, Tyndale RF. Nicotine-metabolizing CYP2B6 enzyme in human brain regions: higher levels in smokers and smoking alcoholics. FASEB J 2001;15:A573.
31. Huang CB. Immunohistochemical localization of cytochrome P450 enzymes 2C and 4A in the normal rat brain. Clin Med J 1998;111:1007-12.
32. Luo G, Zeldin DC, Blaisdell JA, Hodgson E, Goldstein JA. Cloning and expression of murine CYP2Cs and their ability to metabolize arachadonic acid. Arch Biochem Biophys 1998;357:45-57.
33. Riedl AG, Watts PM, Douek DC, Edwards RJ, Boobis AR, Rose S, et al. Expression and distribution of CYP2C enzymes in rat basal ganglia. Synapse 2000;38:392-402.
34. Klose TS, Blaisdell JA, Goldstein JA. Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs. J Biochem Mol Toxicol 1999;13:289-95.
35. Watts PM, Riedl AG, Douek DC, Edwards RJ, Boobis AR, Jenner P, et al. Co-localization of P450 enzymes in the rat substantia nigra with tyrosine hydroxylase. Neurosci 1998;86:511-9.
36. Riedl AG, Watts PM, Edwards RJ, Schulz-Utermoehl T, Boobis AR, Jenner P, et al. Expression and localization of CYP2D enzymes in rat basal ganglia. Brain Res 1999;822:175-91.
37. Tyndale RF, Sunahara R, Inaba T, Kalow W, Gonzalez FJ, Niznik HB. Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6. Mol Pharmacol 1991;40:63-8.
38. Hansson T, Tindberg N, Ingelman-Sundberg M, Kohler C. Regional distribution of ethanol-inducible cytochrome P450 IIEI in the rat central nervous system. Neuroscience 1990;34:451-63.
39. Sohda T, Shimizu M, Kamimura S, Okumura M. Immunohistochemical demonstration of ethanol-inducible P450 2E1 in rat brain. Alcohol Alcohol Suppl 1993;1B:69-75.
40. Tindberg N, Ingelman-Sundberg M. Expression, catalytic activity, and inducibility of cytochrome P450 2E1 (CYP2E1) in the rat central nervous system. J Neurochem 1996;67:2066-73.
41. Yoo M, Ryu HM, Shin SW, Yun CH, Lee SC, Ji YM, et al. Identification of cytochrome P450 2E1 in rat brain. Biochem Biophys Res Commun 1997;231:254-6.
42. Upadhya SC, Tirumalai PS, Boyd MR, Mori T, Ravindranath V. Cytochrome P4502E (CYP2E) in brain: constitutive expression, induction by ethanol and localization by fluorescence in situ hybridization. Arch Biochem Biophys 2000;373:23-34.
43. Boutelet-Bochan H, Huang Y, Juchau MR. Expression of CYP2E1 during embryogenesis and fetogenesis in human cephalic tissues: implications for the fetal alcohol syndrome. Biochem Biophys Res Comm 1997;238:443-7.
44. Brzezinski MR, Boutelet-Bochan H, Person RE, Fantel AG, Juchau MR. Catalytic activity and quantitation of cytochrome P450 2E1 in prenatal human brain. J Pharmacol Exp Ther 1999;289:1648-53.
45. Dai D, Bai R, Hodgson E, Rose RL. Cloning, sequencing, heterologous expression, and characterization of murine cytochrome P450 3a25*(Cyp3a25), a testosterone 6β-hydroxylase. J Biochem Mol Toxicol 2001;15:90-9.
46. Wang H, Kawashima H, Strobel HW. cDNA cloning of a novel CYP3A from rat brain. Biochem Biophys Res Commun 1996;221:157-62.
47. Gellner K, Eiselt R, Hustert E, Arnold H, Koch I, Haberl M, et al. Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics 2001;11:111-21.
48. Murray GI, Pritchard S, Melvin WT, Burke MD. Cytochrome P450 CYP3A5 in the human anterior pituitary gland. FEBS Lett 1995;364:79-82.
49. Kawashima H, Strobel HW. cDNA cloning of three new forms of rat brain cytochrome P450 belonging to the CYP4F subfamily. Biochem Biophys Res Comm 1995;217:1137-44.
50. Stromstedt M, Warner M, Gustafsson JA. Cytochrome P450s of the 4A subfamily in the brain. J Neurochem 1994;63:671-6.
51. Loeper J, Descatoire V, Maurice M, Beaune P, Feldmann G, Larrey D, et al. Presence of functional cytochrome P-450 on isolated rat hepatocyte plasma membrane. Hepatology 1990;11:850-8.
52. Robin M, LeRoy M, Descatoire V, Pessayre D. Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis. J Hepatology 1997;26:23-30.
53. Wu D, Cederbaum AI. Presence of functionally active cytochrome P-450IIEI in the plasma membrane of rat hepatocytes. Hepatology 1992;15:515-24.
54. Honkakoski P, Kojo A, Raunio H, Pasanen M, Juvonen R, Lang MA. Hepatic mitochondrial coumarin 7-hydroxylase: comparison with the microsomal enzyme. Arch Biochem Biophys 1988;267:558-67.
55. Neve EPA, Eliasson E, Pronzato MA, Albano E, Marinari U, Ingelman-Sundberg M. Enzyme-specific transport of rat liver cytochrome P450 to the golgi apparatus. Arch Biochem Biophys 1996;333:459-65.
56. Robin MA, Maratrat M, Loeper J, Durand-Schneider AM, Tinel M, Ballet F, et al. Cytochrome P4502B follows a vesicular route to the plasma membrane in cultured rat hepatocytes. Gastroenterology 1995;108:1110-23.
57. Walther B, Ghersi-Egea JF, Minn A, Siest G. Subcellular distribution of cytochrome P-450 in the brain. Brain Res 1986;375:338-44.
58. Bhagwat SV, Leelavathi BC, Shankar SK, Boyd MR, Ravindranath V. Cytochrome P450 and associated monooxygenase activities in the rat and human spinal cord: induction, immunological characterization and immunocytochemical localization. Neuroscience 1995;68:593-601.
59. Iscan M, Reuhl K, Weiss R, Maines MD. Regional and subcellular distribution of cytochrome P-450-dependent drug metabolism in monkey brain: the olfactory bulb and the mitochondrial fraction have high levels of activity. Biochem Biophys Res Comm 1990;169:858-63.
60. Walther B, Ghersi-Egea JF, Jayyosi Z, Minn A, Siest G. Ethoxyresorufin O-deethylase activity in rat brain subcellular fraction. Neurosci Lett 1987;76:58-62.
61. 2-terminal-processed microsomal protein to mitochondria: A novel pathway for the biogenesis of hepatic mitochondrial P450MT2. J Cell Biol 1997;139:589-99.
62. 2-terminal truncated cytochrome P4501A1 in rat brain during chronic treatment with β-naphthoflavone. J Biol Chemistry 2000;275:34415-23.
63. Hedlund E, Gustafsson J-A, Warner M. Cytochrome P450 in the brain: 2B or not 2B. Trends Pharmacol Sci 1998;19:82-5.
64. Kawashima H, Sequeira DJ, Nelson DR, Strobel HW. Genomic cloning and protein expression of a novel rat brain cytochrome P-450 CYP2D18 catalyzing imipramine N-demethylation. J Biol Chem 1996;271:28176-89.
65. Komori M. A novel P450 expressed at the high level in rat brain. Biochem Biophys Res Comm 1993;196:721-8.
66. Wan J, Imaoka S, Chow T, Hiroi T, Yabusaki Y, Funae Y. Expression of four rat CYP2D isoforms in saccharomyces cerevisiae and their catalytic specificity. Arch Biochem Biophys 1997;348:383-90.
67. Ghersi-Egea JF, Walther B, Perrin R, Minn A, Siest G. Inducibility of rat brain drug-metabolizing enzymes. Eur J Drug Metab Pharmacokinet 1987;12:263-5.
68. Schilter B, Anderson MR, Acharya C, Omiecinski CJ. Activation of cytochrome P450 gene expression in the rat brain by phenobarbital-like inducers. J Pharmacol Exp Ther 2000;294:916-22.
69. Liu L, Bridges RJ, Eyer CL. Effect of cytochrome P450 1A induction on oxidative damage in rat brain. Mol Cell Biochem 2001;223:89-94.
70. Kempermann G, Knoth R, Gebicke-Haerter PJ, Stolz BJ, Volk B. Cytochrome P450 in rat astrocytes in vivo and in vitro: intracellular localization and induction by phenytoin. J Neurosci Res 1994;39:576-88.
71. Rosenbrock H, Hagemeyer CE, Singec I, Knoth R, Volk B. Testosterone metabolism in rat brain is differentially enhanced by phentoin-inducible cytochrome P450 isoforms. J Neuroendocrinol 1999;11:597-604.
72. Baum LO, Strobel HW. Regulation of expression of cytochrome P-450 2D mRNA in rat brain with steroid hormones. Brain Res 1997;765:67-73.
73. Anandatheerthavarada HK, Shankar SK, Bhamre S, Boyd MR, Song B-J, Ravindranath V. Induction of brain cytochrome P450IIEI by chronic ethanol treatment. Brain Res 1993;601:279-85.
74. Montoliu C, Sancho-Tello M, Azorin I, Burgal M, Valles S, Renau-Piqueras J, et al. Ethanol increases cytochrome P4502E1 and induces oxidative stress in astrocytes. J Neurochem 1995;65:2561-70.
75. Montoliu C, Valles S, Renau-Piqueras J, Guerri C. Ethanol-induced oxygen radical formation and lipid peroxidation in rat brain: effect of chronic alcohol consumption. J Neurochem 1994;63:1855-62.
76. Warner M, Gustafsson JA. Effect of ethanol on cytochrome P450 in the rat brain. Proc Natl Acad Sci U S A 1994;91:1019-23.
77. Schoedel KA, Sellers EM, Tyndale RF. Induction of CYP2B1/2 and nicotine metabolism by ethanol in rat liver but not rat brain. Biochem Pharmacol 2001;62:1025-36.
78. Irle E, Markowitsch HJ. Widespread neuroanatomical damage and learning deficits following chronic alcohol consumption or vitamin-B1 (thiamine) deficiency in rats. Behav Brain Res 1983;9:277-94.
79. Anandatheervarada HK, Williams JF, Wecker L. Differential effect of chronic nicotine administration on brain cytochrome P4501A1/2 and P4502E1. Biochem Biophys Res Commun 1993;194:312-8.
80. Anandatheerthavarada HK, WIlliams JF, Wecker L. The chronic administration of nicotine induces cytochrome P450 in rat brain. J Neurochem 1993;60:1941-4.
81. Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 1998;11:559-603.
82. Kreth K, Kovar K, Schwab M, Zanger UM. Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugs. Biochem Pharmacol 2000;59:1563-71.
83. Kumagai Y, Lin LY, Hiratsuka A, Narimatsu S, Suzuki T, Yamada H, et al. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats. Mol Pharmacol 1994;45:359-65.
84. Pellinen P, Kulmala L, Konttila J, Auriola S, Pasanen M, Juvonen R. Kinetic characteristics of norcocaine N-hydroxylation in mouse and human liver. Arch Toxicol 2000;74:511-20.
85. Poet TS, Brendel K, Halpert JR. Inactivation of cytohromes P450 2B protects against cocaine-mediated toxicity. Toxicol Appl Pharmacol 1994;126:26-32.
86. Albores A, Ortega-Mantilla G, Sierra-Santoyo A, Cebrian ME, Munoz-Sanchez JL, Calderon-Salinas JV, et al. Cytochrome P450 2B (CYP2B)-mediated activation of methyl-parathion in rat brain extracts. Toxicol Lett 2001;124:1-10.
87. Bergh AF, Strobel HW. Reconstitution of the brain mixed function oxidase system: purification of NADPH-cytochrome P450 reductase and partial purification of cytochrome P450 from whole brain. J Neurochem 1992;59:575-81.
88. Perrin R, Minn A, Gheris-Egea JF, Grassiot MC, Siest G. Distribution of cytochrome P450 activities towards alkoxyresorufin derivatives in rat brain regions, subcellular fractions, and isolated cerebral microvessels. Biochem Pharmacol 1990;40:2145-51.
89. Ghersi-Egea JF, Perrin R, Leininger-Muller B, Jeandel MCGC, Floquet J, Cuny G, et al. Subcellular localization of cytochrome P450, and activities of several enzymes responsible for drug metabolism in the human brain. Biochem Pharmacol 1993;45:647-58.
90. Ravindranath V, Anandatheerthavarada HK, Shankar SK. Xenobiotic metabolism in human brain-presence of cytochrome P-450 and associated mono-oxygenases. Brain Res 1989;496:331-5.
91. Tyndale RF, Li Y, Li N-Y, Messina E, Miksys S, Sellers EM. Characterization of cytochrome P-450 2D1 activity in rat brain; high-affinity kinetics for dextromethorphan. Drug Metab Dispos 1999;27:924-30.
92. Thompson CM, Kawashima H, Strobel HW. Isolation of partially purified P450 2D18 and characterization of activity toward the tricyclic antidepressants imipramine and desipramine. Arch Biochem Biophys 1998;359:115-21.
93. Dhawan A, Parmar D, Dayal M, Seth PK. Cytochrome P450 (P450) isoenzyme specific dealkylation of alkoxyresorufins in rat brain microsomes. Mol Cell Biochem 1999;200:169-76.
94. Parmar D, Dhawan A, Seth PK. Evidence for O-dealkylation of 7-pentoxyresorufin by cytochrome P450 2B1/2B2 isoenzymes in brain. Mol Cell Biochem 1998;189:201-5.
95. Jolivalt C, Minn A, Vincent-Viry M, Galteau M-M, Siest G. Dextromethorphan O-demethylase activity in rat brain microsomes. Neurosci Lett 1995;187:65-8.
96. Voirol P, Jonzier-Perey M, Porchet F, Reymond MJ, Janzer RC, Bouras C, et al. Cytochrome P-450 activities in human and rat brain microsomes. Brain Res 2000;855:235-43.
97. Coleman T, Spellman EF, Rostami-Hodjegan A, Lennard MS, Tucker GT. The 1′-hydroxylation of Rac-bufuralol by rat brain microsomes. Drug Metab Dispos 2000;28:1094-9.
98. Narimatsu S, Yamamoto S, Koitabashi T, Kato R, Masubuchi Y, Suzuki T, et al. Biphasic kinetics of imipramine N-oxidation in rat brain microsomes. Biol Pharm Bull 1999;22:253-6.
99. Hansson T, vonBahr C, Marklund M, Svensson JO, Ingelman-Sundberg M, Lundstrom J. Different regiospecificity in the hydroxylation of the antidepressant desmethylimipramine between rat brain and liver. Pharmacol Toxicol 1992;71:416-9.
100. Crooks PA, Li M, Dwoskin LP. Metabolites of nicotine in rat brain after peripheral nicotine administration. Drug Metab Dispos 1997;25:47-54.
101. Jacob P 3rd, Ulgen M, Gorrod JW. Metabolism of (-)-(S)-nicotine by guinea pig and rat brain: identification of cotinine. Eur J Drug Metab Pharmacokinet 1997;22:391-4.
102. Laurenzana EM, Owens SM. Brain microsomal metabolism of phencyclidine in male and female rats. Brain Res 1997;756:256-65.
103. Chen AR, Irvine RJ, Bochner F, Somogyi AA. Morphine formation from codeine in rat brain: a possible mechanism of codeine analgesia. Life Sciences 1990;46:1067-74.
104. Lin LY, Kumagai Y, Cho AK. Enzymatic and chemical demethylenation of (methylenedioxy)amphetamine and (methylenedioxy)methamphetamine by rat brain microsomes. Chem Res Toxicol 1992;5:401-6.
105. Forsyth CS, Chambers JE. Activation and degradation of the phosphorothionate insecticides parathion and EPN by rat brain. Biochem Pharmacol 1989;38:1597-603.
106. Michels R, Marzuk PM. Progress in psychiatry (1) [review]. N Engl J Med 1993;329:552-60.
107. Kalow W, Tyndale RF. Debrisoquine.sparteine monooxygenase and other P-450s in brain. In: Kalow W, editor. Pharmacogenetics of drug metabolism. New York: Pergamon Press; 1992. p. 649-56.
108. Fang J, Gorrod JW. Metabolism, pharmacogenetics, and metabolic drug-drug interactions of antipsychotic drugs. Cell Mol Neurobiol 1999;19:491-510.
109. Hiemke C, Hartter S. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther 2000;85:11-28.
110. Parkinson A. Biotransformation of xenobiotics. In: Klaassen CD, editor. Casarett and Doull's toxicology: the basic science of poisons. 5th ed. New York: McGraw-Hill; 1996. p. 113-85.
111. Britto MR, Wedlund PJ. Cytochrome P450 in the brain. Potential evolutionary and therapeutic relevance of localization of drug-metabolizing enzymes. Drug Metabol Dispos 1992;20:446-50.
112. 3H]GBR-12935 binding proteins. Arch Biochem Biophys 1990;276:424-32.
113. Hiroi T, Imaoka S, Funae Y. Dopamine formation from tyramine by CYP2D6. Biochem Biophys Res Commun 1998;249:838-43.
114. Martinez C, Agundez JAG, Gervasini G, Martin R, Benitez J. Tryptamine: a possible endogenous substrate for CYP2D6. Pharmacogenetics 1997;7:85-93.
115. Thompson CM, Capdevila JH, Strobel HW. Recombinant cytochrome P450 2D18 metabolism of dopamine and arachadonic acid. J Pharmacol Exper Ther 2000;294:1120-30.
116. Nissbrandt H, Bergquist F, Jonason J, Engberg F. Inhibition of cytochrome P450 2E1 induces an increase in extracellular dopamine in rat substanti nigra: a new metabolic pathway? Synapse 2001;40:294-301.
117. Boustead C, Taber H, Idle JR, Cholerton S. CYP2D6 genotype and smoking behaviour in cigarette smokers. Pharmacogenetics 1997;7:411-4.
118. Saarikoski ST, Sata F, Husgafvel-Pursiainen K, Rautalahti M, Haukka J, Impivaara O, et al. CYP2D6 ultrarapid metabolizer genotype as a potential modifier of smoking behaviour. Pharmacogenetics 2000;10:5-10.
119. Akhmedova SN, Pushnova EA, Yakimovsky AF, Avtonomov VV, Schwartz EI. Frequency of a specific cytochrome P4502D6B (CYP2D6B) mutant allele in clinically differentiated groups of patients with Parkinson disease. Biochem Mol Med 1995;54:88-90.
120. Kurth MC, Kurth JH. Variant cytochrome P450 CYP2D6 alleleic frequencies in Parkinson's disease. Am J Med Genet 1993;48:166-8.
121. Tsuneoka Y, Matsuo Y, Iwahashi K, Takeuchi H, Ichikawa Y. A novel cytochrome P-450IID6 mutant gene associated with Parkinson's disease. J Biochem 1993;114:263-6.
122. Yoshino H, Hattori Y, Imai H, Narabayashi H, Chiba K. Sparteine oxidation by hepatic cytochrome P-450 in patients with Parkinson's disease [In Japanese]. Rinsho Shinkeigaku 1993;33:261-5.
123. Riedl AG, Watts PM, Brown CT, Jenner P. P450 and heme oxygenase enzymes in the basal ganglia and their roles in Parkinson's disease. Adv Neurol 1999;80:271-86.
124. Riedl AG, Watts PM, Jenner P, Marsden CD. P450 enzymes and Parkinson's disease: the story so far. Mov Disord 1998;13:212-20.
125. Chen X, Xia Y, Alford M, DeTeresa R, Hansen L, Klauber MR, et al. The CYP2D6B allele is associated with a milder synaptic pathology in Alzheimers disease. Ann Neurol 1995;38:653-8.
126. Saitoh T, Xia Y, Chen X, Masliah E, Galasko D, Shults C, et al. The CYP2D6B mutant allele is overrepresented in the Lewy body vaiant of Alzheimer's disease. Ann Neurol 1995;37:110-2.
127. Tanaka S, Chen X, Xia Y, Kang DE, Matoh N, Sundsmo M, et al. Association of CYP2D microsatellite polymorphism with Lewy body variant of Alzheimer's disease. Neurology 1998;50:1556-62.
128. Gervasini G, Martinez C, Agundez AAG, Garcia-Gamito FJ, Benitez J. Inhibition of cytochrome P450 2C9 activity in vitro by 5-hydroxytryptamine and adrenaline. Pharmacogenetics 2001;11:29-37.
129. Daikh BE, Lasker JM, Raucy JL, Koop DR. Regio- and stereoselective epoxidation of arachidonic acid aby human cytochromes P450 2C8 and 2C9. J Pharmacol Exp Ther 1994;271:1427-33.
130. Qu W, Bradbury JA, Tsao C, Maronpot R, Harry GJ, Parker CE, et al. Cytochrome P450 CYP2J9, a new mouse arachidonic acid ω-1 hydroxylase predominantly expressed in brain. J Biol Chem 2001;276:25467-79.
131. Rifkind AB, Lee C, Chang TK, Waxman DJ. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. Arch Biochem Biophys 1995;320:380-9.
132. Simpson AE. The cytochrome P450 4 (CYP4) family. Gen Pharmac 1997;28:351-9.
133. Zeldin DC, DuBois RN, Falck JR, Capdevila JH. Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform. Arch Biochern Biophys 1995;322:76-86.
134. Zeldin DC, Foley J, Ma J, Boyle JE, Pascual JM, Moomaw CR, et al. CYP2J subfamily P450s in the lung: expression, localization, and potential functional significance. Mol Pharmacol 1996;50:1111-7.
135. Zeldin DC, Plitman JD, Kobayashi J, Miller RF, Snapper JR, Falck JR, et al. The rabbit pulmonary cytochrome P450 arachidonic acid metabolic pathway; characterization and significance. J Clin Invest 1995;95:2150-60.
136. Capdevila JH, Zeldin D, Makita K, Karara A, Falck JR. Cytochrome P450 and the metabolism of arachidonic acid and oxygenated eicosanoids. In: Ortiz de Montellano PR, editor. Cytochrome P450: structure, mechanism, biochemistry. New York: Plenum Press; 1995. p. 443-71.
137. Alkayed NJ, Birks EK, Hudetz AG, Roman RJ, Henderson L, Harder DR. Inhibition of brain P-450 arachidonic acid epoxygenase decreases baseline cerebral blood flow. Am J Physiol 1996;271:1541-6.
138. Alkayed NJ, Narayanan J, Gebremedhin D, Medhora M, Roman RJ, Harder DR. Molecular characterization of an arachidonic acid epoxygenase in rat brain astrocytes. Stroke 1996;27:971-9.
139. Amruthesh SC, Falck JR, Ellis EF. Brain synthesis and cerebrovascular action of epoxygenase metabolites of arachidonic acid. J Neurochem 1992;58:503-10.
140. Ellis EF, Police RJ, Yancey L, McKinney JS, Amruthesh SC. Dilation of cerebral arterioles by cytochrome P-450 metabolites of arachidonic acid. Am J Physiol 1990;259:H1171-7.
141. Gebremedhin D, Lange AR, Lowry TF, RezaTaheri M, Birks EK, Hundetz AG, et al. Production of 20-HETE and its role in autoregulation of cerebral blood flow. Circ Res 2000;87:60-5.
142. Gebremedhin D, Ma YH, Falck JR, Roman RJ, VanRollins M, Harder DR. Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle. Am J Physiol 1992;263:519-25.
143. Harder DR, Roman RJ, Gebremedhin D, Birks EK, Lange AR. A common pathway for regulation of nutritive blood flow to the brain: arterial muscle membrane potential and cytochrome P450 metabolites. Acta Physiol Scand 1998;164:527-32.
144. Capdevila J, Chacos N, Falck JR, Manna S, Negro-Vilar A, Ojeda SR. Novel hypothalamic arachidonate products stimulate somatostatin release from the median eminence. Endocrinology 1983;113:421-3.
145. Cashman JR, Hanks D, Weiner RI. Epoxy derivatives of arachidonic acid are potent stimulators of prolactin secretion. Neuroendocrinology 1987;46:246-51.
146. Junier MP, Dray F, Blair I, Capdevila J, Dishman E, Falck JR, et al. Epoxygenase products of arachidonic acid are endogenous constituents of the hypothalamus involved in D2 receptor-mediated, dopamine-induced release of somatostatin. Endocrinology 1990;126:1534-40.
147. Junier MP, Israel JM, Dray F, Vincent JD. Contribution of arachidonate metabolites to basal and thyrotropin releasing-hormone-stimulated release of prolactin from purified lactotrophs in primary culture. Life Sci 1990;47:1829-36.
148. Snyder GD, Capdevila J, Chacos N, Manna S, Falck JR. Action of luteinizing hormone-releasing hormone: involvement of novel arachidonic acid metabolites. Proc Natl Acad Sci U S A 1983;80:3504-7.
149. Gebremedhin D, Lange AR, Narayanan J, Aebly MR, Jacobs ER, Harder DR. Cat cerebral arterial smooth muscle cells express cytochrome P450 4A2 enzyme and produce the vasoconstrictor 20-HETE which enhances L-type Ca2+ current. J Physiol 1998;507:771-81.
150. Stoffel-Wagner B. Neurosteroid metabolism in the human brain. Eur J Endocrinol 2001;145:669-79.
151. Tsutsui K, Ukena K, Takase M, Kohchi C, Lea RW. Neurosteroid biosynthesis in vertebrate brains. Comp Biochem Physiol C 1999;124:121-9.
152. Warner M, Gustafsson J-A. Cytochrome P450 in the brain: neuroendocrine functions. Front Neuroendocrinol 1995;16:224-36.
153. Kimoto T, Tsurugizawa T, Ohta Y, Makino J, Tamura H, Hojo Y, et al. Neurosteroid synthesis by cytochrome p450-containing systems localized in the rat brain hippocampal neurons: N-methyl-D-aspartate and calcium-dependent synthesis. Endocrinology 2001;142:3578-89.
154. Zwain IH, Yen SS. Dehydroepiandrosterone: biosynthesis and metabolism in the brain. Endocrinology 1999;140:880-7.
155. Zwain IH, Yen SS. Neurosteroidogenesis in astrocytes, oligodendrocytes and neurons of cerebral cortex of rat brain. Endocrinolgy 1999;140:3843-52.
156. Badawi AF, Cavalieri EL, Rogan EG. Role of human cytochrome P450 1A1, 1A2, 1B1 and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol. Metabolism 2001;50:1001-3.
157. Doostzadeh J, Cotillon AC, Morfin R. Dehydroepiandrosterone 7alpha- and 7beta-hydroxylation in mouse brain micrsomes. Effects of cytochrome P450 inhibitors and structure-specific inhibition by steroid hormones. J Neuroendocrinol 1997;9:923-8.
158. Doostzadeh J, Morfin R. Effects of cytochrome P450 inhibitors and of steroid hormones on the formation of 7-hydroxylated metablites of pregnenolone in mouse brain microsomes. J Endocrinol 1997;155:343-50.
159. Doostzadeh J, Urban P, Pompon D, Morfin R. Pregnenolone-7 beta-hydroxylating activities of yeast expressed mouse cytochrome P450-1A1 and mouse-tissue microsomes. Eur J Biochem 1996;242:641-7.
160. Hiroi T, Kishimoto W, Chow T, Imaoka S, Igarashi T, Funae Y. Progesterone oxidation by cytochrome P450 2D isoforms in the brain. Endocrinology 2001;142:3901-8.
161. Wang H, Napoli KL, Strobel HW. Cytochrome P450 3A9 catalyzes the metabolism of progesterone and other steroid hormones. Mol Cell Biochem 2000;213:127-35.
162. Bean R, Seckl JR, Lathe R, Martin C. Ontogeny of the neurosteroid enzyme Cyp 7b in the mouse. Mol Cell Endocrinol 2001;174:137-44.
163. Rose K, Allan A, Gauldie S, Stapleton G, Dobbie L, Dott K, et al. Neurosteroid hydroxylase CYP7B vivd reporter activity in dentate gyrus of gene-targeted mice and abolition of a widspread pathway of steroid and oxysterol hydroxylation. J Biol Chem 2001;276:23937-44.
164. Rose KA, Stapleton G, Dott K, Kieny MP, Best R, Schwarz M, et al. Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7 alpha-hydroxy dehydroepiandrosterone and 7 alpha-hydroxy pregnenolone. Proc Natl Acad Sci U S A 1997;94:4925-30.
165. Bergh AF, Strobel HW. Anatomical distribution of NADPH-cytochrome P450 reductase and cytochrome P4502D forms in rat brain: effects of xenobiotics and sex steroids. Mol Cell Biochem 1996;162:31-41.